Insights for HR and benefits leaders on the impact of poor sleep on employees.

A case study examining Sleepio adoption and outcomes in employees of an integrated automotive services company.

These days, stressful news comes in through our emails and phone alerts on a daily basis, taking a heavy toll on the mental health of many employees. It’s not surprising, then, that insomnia and anxiety are on the rise. Between 30-35% of US adults experience symptoms of insomnia, while 19.1% of US adults have an anxiety disorder. Subscribe today...

This whitepaper closely examines digital treatments — with a particular focus on solutions rooted in cognitive behavioral therapy (CBT). By weighing the pros and cons of each category, you can determine which digital treatment options best suit your organization’s unique needs.

When insomnia and anxiety occur together, their effects can compound. A remarkable 24% to 36% of people with anxiety disorders experience insomnia, while people with insomnia are more likely to develop an anxiety disorder than those without sleep issues.

Now more than ever, it’s crucial for companies to invest in effective workforce solutions for managing insomnia and anxiety. In this guide, we explore the key factors to consider so you can select a solution that meets the needs of your employees and supports a healthy workplace culture.

While benzodiazepine and hypnotic medications are generally not indicated as first-line treatments for insomnia and anxiety, an alarming number of patients are being treated with these medications as the first and only treatment. Big Health recently engaged Milliman to conduct a study on treatment patterns for traditional Medicare beneficiaries with insomnia disorder and generalized anxiety...

Nearly 20% of US adults struggle with an anxiety disorder — a constant cycle of worry that takes a toll on physical and mental health, interferes with everyday functioning, and impacts every aspect of daily life, from family relationships to careers.

Studies show that more than 40% of adult Americans experienced significant anxiety or depressive symptoms during the pandemic, yet for many, affordable quality mental health care is not within reach.